Cue Biopharma, Inc.CUENASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-36.40M
↓ 34% below average
Average (9y)
$-27.26M
Historical baseline
Range
High:$-2.41M
Low:$-41.98M
CAGR
+35.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-36.40M | +8.9% |
| 2023 | $-39.96M | +4.8% |
| 2022 | $-41.98M | -5.6% |
| 2021 | $-39.75M | -20.1% |
| 2020 | $-33.09M | -7.3% |
| 2019 | $-30.84M | -9.1% |
| 2018 | $-28.27M | -111.0% |
| 2017 | $-13.40M | -106.6% |
| 2016 | $-6.48M | -168.9% |
| 2015 | $-2.41M | - |